# Press Releases

## All News

### News TypeNewsPress Releases

#### By Year

- [November 18, 2025 \ Nuvig Therapeutics Appoints Celia J.F. Lin, M.D., as Chief Medical Officer](https://nuvigtx.com/nuvig-therapeutics-appoints-celia-j-f-lin-m-d-as-chief-medical-officer/)  
- [September 9, 2025 \ Nuvig Therapeutics Appoints David J. Woodhouse, Ph.D., as Chief Executive Officer and James Mackay, Ph.D., as Independent Board Chair](https://nuvigtx.com/nuvig-therapeutics-appoints-david-j-woodhouse-ph-d-as-chief-executive-officer-and-james-mackay-ph-d-as-independent-board-chair/)  
- [May 14, 2025 \ Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 Data](https://nuvigtx.com/nuvig-therapeutics-announces-first-patient-dosed-in-phase-2-cidp-trial-of-nvg-2089-and-presentation-of-phase-1-data/)  
- [December 5, 2024 \ Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator](https://nuvigtx.com/nuvig-therapeutics-announces-161-million-series-b-financing-and-progression-to-phase-2-development-with-novel-second-generation-immunomodulator/)  
- [February 12, 2024 \ Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089](https://nuvigtx.com/nuvig-initiates-clinical-development-of-next-generation-immune-modulator-nvg-2089/)  
- [October 4, 2023 \ Nuvig Therapeutics Appoints Dr. Alan Glicklich Chief Medical Officer](https://nuvigtx.com/nuvig-therapeutics-appoints-dr-alan-glicklich-chief-medical-officer/)  
- [May 11, 2022 \ Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases](https://nuvigtx.com/nuvig-launches-to-develop-novel-immune-therapeutics-for-chronic-inflammatory-and-autoimmune-diseases/)

**reCAPTCHA**

Recaptcha requires verification.

protected by **reCAPTCHA**